With <7 minutes hands-on time, the Quick SARS-CoV-2 rRT-PCR kit from Zymo Research has a limit of detection of 15 viral genomic copies/reaction. Supplied as a ready-to-use master mix with a 3-step workflow, this kit detects three RNA regions from the nucleocapsid (N) gene of SARS-CoV-2, responsible for COVID-19. Pure RNA from clinical sources, such as upper and lower respiratory specimens, is to be used with this kit.
Compatibility and validation
The kit is compatible with real-time PCR instruments that are able to detect the fluorescent dyes HEX™ and Quasar® 670/Cy® 5. It is also validated on the BioRad CFX96 as part of the FDA EUA authorised end to end COVID testing workflow. Comprehensive technical support is available for all steps of the setup process and data interpretation.
This kit contains a CV positive control and a no template control as well as detecting one host-specific region (human RNase P gene) to assess sample quality.
Features of the Quick SARS-CoV-2 rRT-PCR kit
• 15 viral genomic copies/reaction LOD
• Ready to go master mix
• < 7 min hands on time
• High throughput workflow
• CV positive and no template controls included
• Technical support available for all steps of the setup process and data interpretation
The Quick SARS-CoV-2 rRT-PCR limit of detection (LOD) is as little as 15 genome equivalent copies per reaction (GEC/reaction) or 250 GEC per milliliter of specimen, for manual and automated rRT-PCR setup. Samples with concentrations of 5 and 10 copies/reaction have 75 and 85 percent of detection, respectively.
Note: product availability depends on country - see product detail page.
|Details||Cat number & supplier||Size||Price|
|Quick SARS-CoV-2 rRT-PCR Kit R3011 · Zymo Research||
|Quick SARS-CoV-2 rRT-PCR Kit R3011-1K · Zymo Research||
|Quick SARS-CoV-2 rRT-PCR Kit R3011-10K · Zymo Research||